66 related articles for article (PubMed ID: 27288791)
1. Corrigendum to 'Arachidonate 5-Lipoxygenase (ALOX5) gene polymorphism is associated with Alzheimer's disease and body mass index [Šerý et al., J. Neurol. Sci. 362 (2016) 27-32].
Šerý O; Hlinecká L; Povová J; Bonczek O; Zeman T; Janout V; Ambroz P; Khan NA; Balcar VJ
J Neurol Sci; 2016 Jul; 366():135. PubMed ID: 27288791
[No Abstract] [Full Text] [Related]
2. Arachidonate 5-lipoxygenase (ALOX5) gene polymorphism is associated with Alzheimer's disease and body mass index.
Šerý O; Hlinecká L; Povová J; Bonczek O; Zeman T; Janout V; Ambroz P; Khan NA; Balcar VJ
J Neurol Sci; 2016 Mar; 362():27-32. PubMed ID: 26944113
[TBL] [Abstract][Full Text] [Related]
3. 5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's disease.
Manev H; Manev R
Med Hypotheses; 2006; 66(3):501-3. PubMed ID: 16278051
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and functional characterization of arachidonate 5-lipoxygenase (Alox5), and its expression in response to the ratio of linolenic acid to linoleic acid in diets of large yellow croaker (Larmichthys crocea).
Wang T; Zuo R; Mai K; Xu W; Ai Q
Comp Biochem Physiol B Biochem Mol Biol; 2016 Nov; 201():21-8. PubMed ID: 27378407
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum to 'Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease' [J. Neurol. Sci. 370 (November 2016) 162-166].
Porcelli S; Crisafulli C; Donato L; Calabrò M; Politis A; Liappas I; Albani D; Atti AR; Salfi R; Raimondi I; Forloni G; Papadimitriou GN; De Ronchi D; Serretti A
J Neurol Sci; 2017 Jan; 372():49. PubMed ID: 28017245
[No Abstract] [Full Text] [Related]
6. Cardioprotective effect of 5-lipoxygenase gene (ALOX5) silencing in ischemia-reperfusion.
Lisovyy OO; Dosenko VE; Nagibin VS; Tumanovska LV; Korol MO; Surova OV; Moibenko OO
Acta Biochim Pol; 2009; 56(4):687-94. PubMed ID: 20011686
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness.
Kim SH; Bae JS; Suh CH; Nahm DH; Holloway JW; Park HS
Allergy; 2005 Jun; 60(6):760-5. PubMed ID: 15876305
[TBL] [Abstract][Full Text] [Related]
8. Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):502-8. PubMed ID: 16537708
[TBL] [Abstract][Full Text] [Related]
9. 5-Lipoxygenase gene polymorphism and onset of Alzheimer's disease.
Manev H
Med Hypotheses; 2000 Jan; 54(1):75-6. PubMed ID: 10790729
[TBL] [Abstract][Full Text] [Related]
10. A functional Sp1/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene is not associated with myocardial infarction.
González P; Reguero JR; Lozano I; Morís C; Coto E
Int J Immunogenet; 2007 Apr; 34(2):127-30. PubMed ID: 17373938
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase.
Choi JH; Park HS; Oh HB; Lee JH; Suh YJ; Park CS; Shin HD
Hum Genet; 2004 Mar; 114(4):337-44. PubMed ID: 14749922
[TBL] [Abstract][Full Text] [Related]
12. [SiRNA-mediated silencing of 5-lipoxygenase gene (ALOX5) reduces necrosis of neonatal cardiomyocytes in anoxia-reoxygenation].
Lisovyĭ OO; Nahibin VS; Surova OV; Tumanovs'ka LV; Dosenko BIe; Moĭbenko OO
Fiziol Zh (1994); 2009; 55(3):37-43. PubMed ID: 19526855
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment.
Drazen JM; Yandava CN; Dubé L; Szczerback N; Hippensteel R; Pillari A; Israel E; Schork N; Silverman ES; Katz DA; Drajesk J
Nat Genet; 1999 Jun; 22(2):168-70. PubMed ID: 10369259
[TBL] [Abstract][Full Text] [Related]
14. Protection from hepatic lipid accumulation and inflammation by genetic ablation of 5-lipoxygenase.
Titos E; Ferré N; Lozano JJ; Horrillo R; López-Parra M; Arroyo V; Clària J
Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):54-61. PubMed ID: 20227514
[TBL] [Abstract][Full Text] [Related]
15. Leukotriene-related gene polymorphisms in patients with aspirin-intolerant urticaria and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population.
Kim SH; Choi JH; Holloway JW; Suh CH; Nahm DH; Ha EH; Park CS; Park HS
J Korean Med Sci; 2005 Dec; 20(6):926-31. PubMed ID: 16361798
[TBL] [Abstract][Full Text] [Related]
16. ALOX5 variants associated with susceptibility to human pulmonary tuberculosis.
Herb F; Thye T; Niemann S; Browne EN; Chinbuah MA; Gyapong J; Osei I; Owusu-Dabo E; Werz O; Rüsch-Gerdes S; Horstmann RD; Meyer CG
Hum Mol Genet; 2008 Apr; 17(7):1052-60. PubMed ID: 18174194
[TBL] [Abstract][Full Text] [Related]
17. ALOX5 promoter genotype, asthma severity and LTC production by eosinophils.
Kalayci O; Birben E; Sackesen C; Keskin O; Tahan F; Wechsler ME; Civelek E; Soyer OU; Adalioglu G; Tuncer A; Israel E; Lilly C
Allergy; 2006 Jan; 61(1):97-103. PubMed ID: 16364163
[TBL] [Abstract][Full Text] [Related]
18. Functional variants of the human 5-lipoxygenase gene and their genetic diagnosis.
Geiger EV; Doehring A; Kirchhof A; Lötsch J
Prostaglandins Leukot Essent Fatty Acids; 2009; 80(5-6):255-62. PubMed ID: 19446447
[TBL] [Abstract][Full Text] [Related]
19. The Sp1/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene promoter is not associated with late onset Alzheimer disease.
Alvarez V; González P; Corao AI; Menéndez M; Lahoz CH; Martínez C; Calatayud M; Morales B; Coto E
Alzheimer Dis Assoc Disord; 2008; 22(2):177-80. PubMed ID: 18525291
[TBL] [Abstract][Full Text] [Related]
20. Candidate genes of the 5-lipoxygenase pathway in acute coronary syndrome: a pilot study.
Wung SF; Aouizerat BE
Biol Res Nurs; 2008 Apr; 9(4):280-92. PubMed ID: 18398223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
